- ISIS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $68.8 million.
- ISIS is up 2.4% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ISIS with the Ticky from Trade-Ideas. See the FREE profile for ISIS NOW at Trade-Ideas More details on ISIS: Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. Currently there are 4 analysts that rate Isis Pharmaceuticals a buy, 1 analyst rates it a sell, and 2 rate it a hold. The average volume for Isis Pharmaceuticals has been 2.3 million shares per day over the past 30 days. Isis has a market cap of $6.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.63 and a short float of 15% with 11.94 days to cover. Shares are up 33.1% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: